Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8, Ireland.
Drug Test Anal. 2012 Jan;4(1):33-8. doi: 10.1002/dta.362. Epub 2011 Nov 18.
3β-(4-Fluorobenzoyloxy)tropane (3β-FBT, fluorotropacocaine) was first reported by Finnish authorities to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) via the Early Warning System (EWS) in 2008 and our own laboratory tentatively identified it in 2010 in several products purchased from head shops. Very little is known about this cocaine-like drug and, as no reference standards were available, we have synthesized and characterized both 3β-FBT and its 3α isomer for use as reference standards. The two compounds are separable by gas chromatography (GC) but their electron-impact (EI) mass spectra were found to be almost identical. ¹⁹F NMR spectroscopy was also found to be a useful technique for distinguishing the two isomers.
3β-(4-氟苯甲酰氧基)托烷(3β-FBT,氟他喹酮)于 2008 年首次由芬兰当局通过早期预警系统(EWS)向欧洲毒品和毒瘾监测中心(EMCDDA)报告,我们自己的实验室也于 2010 年在从摇头丸商店购买的几种产品中初步确定了它的存在。关于这种类似可卡因的药物知之甚少,由于没有参考标准,我们已经合成并表征了 3β-FBT 及其 3α 异构体,用作参考标准。这两种化合物可以通过气相色谱(GC)分离,但它们的电子冲击(EI)质谱几乎相同。¹⁹F NMR 光谱也被发现是区分这两种异构体的有用技术。